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Abstract Resolution of neutrophil mediated inflammation is
achieved, in part, through induction of neutrophil apoptosis. This
constitutively expressed programme can be delayed by inflam-
matory mediators and induced by ligation of the Fas receptor.
However, functional activation of the neutrophil results in
resistance to Fas signalled death. We evaluated the effects of
Fas antibody engagement on caspase activation and mitochon-
drial permeability, and the impact of co-stimulation by
lipopolysaccharide (LPS) or granulocyte macrophage-colony
stimulating factor (GM-CSF) on these events. Fas engagement
by an agonistic anti-Fas antibody resulted in enhanced caspase 3
and 8 activity and increased mitochondrial permeability. Studies
with pharmacological inhibitors of caspase activity showed that
activation of caspase 8 occurred before, and activation of caspase
3 occurred after mitochondrial disruption. The mitochondrial
stabilising agent bongkrekic acid also inhibited caspase activa-
tion and apoptosis. LPS, GM-CSF and increased glutathione
stabilised the mitochondria and inhibited caspase 3. Caspase 8
activity was also inhibited by co-stimulation through a mecha-
nism independent of mitochondrial stabilisation. Glutathione
directly inhibited caspase 3 and 8 activity. We conclude inhibition
of Fas antibody induced apoptosis by inflammatory proteins is
associated with augmented mitochondrial stability and reduced
caspase 3 activity that may be glutathione mediated.
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1. Introduction
An in£ammatory response is terminated, in part, through
apoptosis of its cellular e¡ectors [1]. Neutrophils die sponta-
neously by apoptosis in vitro and in vivo. This constitutively
expressed programme can be regulated by a number of in£am-
matory mediators and processes [2^9].
Di¡erent apoptotic processes including Fas ligation mediate
their e¡ects through activation of a cascade of proteolytic
enzymes known as caspases [10]. Mitochondrial permeabilisa-
tion has also been shown to activate caspases through the
release of cytochrome c (Apaf-2) [11]. Which pathway is cen-
tral to Fas antibody induced neutrophil apoptosis is un-
known. In£ammatory neutrophils are resistant to pro-apop-
totic signals resulting from Fas ligation [7,12]. This resistance
is associated with an increase in intracellular levels of reduced
glutathione (GSH) [7] and altered caspase expression [12].
This delay in apoptosis is associated with the production of
survival mechanisms [13^15]. How these mechanisms mediate
their e¡ects and if they involve caspase and mitochondrial
components is unknown. We hypothesised that Fas antibody
induced neutrophil apoptosis is caspase dependent and resist-
ance of neutrophils to pro-apoptotic stimuli within an in£am-
matory milieu may result from altered caspase activity.
Here we demonstrate that anti-Fas antibody induced neu-
trophil apoptosis is associated with increased caspase 3 and 8
activity, and disruption of the mitochondrial membrane.
Caspase inhibition studies suggest a role for caspase 8 in
mitochondrial disruption and the subsequent activation of
caspase 3. We show that mitochondrial disruption alone in-
duces caspase 3 and apoptosis, independent of caspase 8 ac-
tivity. We present evidence that lipopolysaccharide (LPS),
granulocyte macrophage-colony stimulating factor (GM-
CSF) and N-acetylcysteine (NAC) inhibit the e¡ects of Fas
ligation, by stabilising mitochondria and inhibiting caspase
activity. Finally, we demonstrate that glutathione directly in-
hibits caspase activity in a cell free system.
2. Materials and methods
2.1. Reagents
Dulbecco’s modi¢ed Eagle’s medium (DMEM), penicillin and
streptomycin solution, L-glutamine, phosphate bu¡ered saline (PBS)
and foetal calf serum (FCS) were purchased from Gibco Life Tech-
nologies Ltd, Burlington, Ont., Canada. Z-DEVD-FMK and Z-
IETD-FMK were purchased from Enzyme Systems Products, Dublin,
CA, USA. Annexin V was from Genzyme, Cambridge, MA, USA.
3,3P-Dihexyloxacarbocyanine iodide (DiOC6) was purchased from
Molecular Probes, Eugene, OR, USA. Dextran and Ficoll were
from Pharmacia, Uppsala, Sweden. All other chemicals were supplied
by Sigma-Aldrich, Dorset, UK, unless otherwise stated. Bongkrekic
acid was kindly donated by Prof. J.A. Duine through Prof. Hiroshi
Terada.
2.2. Neutrophil isolation
Neutrophils were isolated from six di¡erent healthy volunteers by
dextran sedimentation and centrifugation through a discontinuous
Ficoll gradient [5] and these cells were used in all experiments. Iso-
lated neutrophils were resuspended at a concentration of 1U106 cells/
ml in DMEM supplemented with 10% foetal calf serum, 1% glutamine
and 1% penicillin/streptomycin solution. Cells were incubated in poly-
propylene tubes to prevent adherence. Neutrophil purity, assessed by
size and granularity on £ow cytometry, was consistently greater than
95% (each n represents results from one individual volunteer).
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2.3. Quanti¢cation of apoptosis
Neutrophil apoptosis was quantitated as the percent of cells with
hypodiploid DNA [5] and annexin V binding. Cells were centrifuged
at 200Ug for 10 min, then gently resuspended in 500 Wl of hypotonic
£uorochrome solution (50 Wg/ml propidium iodide, 3.4 mM sodium
citrate, 1 mM Tris, 0.1 mM EDTA, 0.1% Triton X-100) and stored in
the dark at 4‡C before analysis using a Coulter ELITE cyto£uorom-
eter (Coulter Electronics, Bedfordshire, UK). For annexin V binding
experiments, neutrophils (1U106) were pelleted and incubated with
200 ml of annexin V antibody bu¡er (10 WM) for 20 min at 4‡C
and then washed with cold PBS before analysis by £ow cytometry.
All measurements were performed under the same instrument settings.
2.4. Caspase activity assay
Cell lysates were prepared from 10U106 neutrophil membrane frac-
tions after di¡erent treatments. Aliquots of the lysates (250 Wl) were
diluted in assay bu¡er (100 mM HEPES, pH 7.5, 10% sucrose, 0.1%
CHAPS) containing 20 WM CBZ-Asp-Glu-Val-Asp-AFC (caspase 3
substrate) or CBZ-Ile-Glu-Thr-Asp-AFC (caspase 8 substrate) (En-
zyme Systems, Livermore, CA, USA), and incubated for 45 min at
room temperature. The release of AFC was detected by continuous
measurement in a luminescence spectrometer (Perkin Elmer LS30,
London, UK) with an excitation of 400 nm and an emission slit at
505 nm. Speci¢c activity is measured as pmol/s mg protein.
2.5. Mitochondrial permeability assay
Neutrophil mitochondrial permeability was measured using DiOC6
(¢nal concentration 40 nM, excitation wavelength 488 nm, emission
529 nm) [16]. Brie£y, neutrophils (1U106/ml) were incubated with
DiOC6 for 20 min at 37‡C and then washed with cold PBS. Samples
were stored on ice until analysis by £ow cytometry. All cells were
included for analyses by side and forward scatter.
2.6. Western blot analysis
Whole cell protein extracts were isolated from 2U106 human neu-
trophils, and run on a 12% SDS polyacrylamide gradient gel, then
electrophoretically transferred to Immobilon-P (Millipore, Bedford,
MA, USA). Blots were incubated with caspase 3 primary antibody
(1:1000, Transduction Laboratories, Lexington, KY, USA) in 1%
BSA TBS and 0.1% Tween 20 for 1 h at room temperature and
then incubated with horseradish peroxidase conjugated anti-mouse
IgG at 1:5000 dilution for 1 h. Blots were developed using an en-
hanced chemiluminescence system.
2.7. Statistics
Statistical analysis was carried out using ANOVA with Sche¡ee¤
correction. Signi¢cance was assumed for values of P6 0.05.
3. Results and discussion
3.1. Anti-Fas antibody induced neutrophil apoptosis is
associated with increased caspase 3 and 8 activity and
enhanced mitochondrial permeability
Engagement of the Fas receptor leads to the initiation of
the caspase cascade and induction of apoptosis [10]. Previous
studies have demonstrated that an agonistic antibody to Fas
(clone CH-11) induces neutrophil apoptosis [7,17]. The ability
of anti-Fas antibody to induce neutrophil apoptosis was con-
¢rmed in this study by staining of DNA with propidium io-
dide, and by assessment of annexin V binding (the latter rec-
ognises phosphatidylserine expressed on the exterior of
apoptotic cells). Propidium iodide DNA staining resulted in
a signi¢cant (P6 0.05) increase in apoptosis from 26 þ 5%
apoptosis in control neutrophils to 61 þ 10% apoptosis in
Fas antibody treated neutrophils at 24 h. The percent neutro-
phils expressing FITC labelled annexin V at 6 h was signi¢-
cantly increased with anti-Fas treatment (48 þ 12% apoptosis)
compared to control neutrophils (25 þ 7% apoptosis). Anti-
Fas also induced a signi¢cant increase in caspase 3 and 8
activity at 4 and 6 h (Fig. 1a). Cleavage of pro-caspase 3
and 8 was con¢rmed by Western blotting, which demon-
strated that Fas ligation decreases pro-caspase 3 and 8 protein
expression (Fig. 1b). The caspase antibodies used in this study
do not recognise active forms of the corresponding caspase as
has been shown by Sanghavi et al. [20]. Many studies have
demonstrated that ligation of the Fas receptor causes recruit-
ment of FADD/MORT1 and activation of caspase 8 [10]. In
addition recent studies have demonstrated a role for caspases
in tumour necrosis factor-K (TNF-K) induced neutrophil
apoptosis [18].
Mitochondrial permeability (Fig. 1c) was also signi¢cantly
increased at 3, 6 and 9 h. This disruption has also been asso-
ciated with the early stages of apoptosis in a number of cell
types [16,19]. Cytochrome c (Apaf-2), a mitochondrial pro-
tein, activates caspase 3 through caspase 9 (Apaf 3) cleavage
[10]. Indeed it is uncertain whether caspases or mitochondria
serve as the central e¡ectors of apoptosis : caspases open
megachannels in mitochondria resulting in apoptosis, while
mitochondrial protein release is required for caspase activa-
tion [20,21].
3.2. E¡ects of caspase 3 and 8 inhibitors on anti-Fas antibody
induced caspase activity and mitochondrial permeability
To determine the sequence of events by which engagement
of Fas induces apoptosis, neutrophils were treated with anti-
Fas antibody 1 h after incubation with the caspase 3 inhibitor
Z-DEVD-FMK, 100 WM, or the caspase 8 inhibitor, Z-IETD-
FMK, 100 WM. Anti-Fas antibody induced apoptosis was
Fig. 1. E¡ects of anti-Fas antibody on (a) caspase 3 and 8 activity,
(b) protein expression and (c) mitochondrial permeability. Normal
neutrophils were incubated with anti-Fas antibody (CH-11, 100 ng/
ml) and assessed for (a) caspase 3 and 8 activity over time (0^6 h)
using AFC labelled substrates, CBZ-Asp-Glu-Val-Asp-AFC (caspase
3) or CBZ-Ile-Glu-Thr-Asp-AFC (caspase 8). b: Total protein was
also isolated at 0, 2, 4 and 6 h and SDS-PAGE Western blotting
carried out to determine the expression of pro-caspase 3 and 8. Blot
represents one of three experiments. c: Mitochondrial permeability
was assessed at 0, 3, 6 and 9 h by assessing DiOC6 £uorescence in-
tensity using £ow cytometry. *P6 0.05 vs spontaneous neutrophils,
n = 6.
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signi¢cantly inhibited at 18 h by both inhibitors (Fig. 2a).
Apoptosis was also assessed by annexin V binding at 6 h.
Similar e¡ects of caspase inhibition were seen when apoptosis
was evaluated by annexin V binding (DEVD-FMK 31 þ 8%
apoptosis, Z-IETD-FMK 29 þ 9% apoptosis, P6 0.05). Inhib-
ition of apoptosis by either inhibitor was associated with a
corresponding decrease in caspase 3 activity (Fig. 2a). Caspase
8 inhibition both prevented caspase 8 activity and increased
mitochondrial permeability (Fig. 2a), suggesting that activa-
tion of caspase 8 precedes mitochondrial disruption, whereas
caspase 3 follows mitochondrial disruption.
3.3. Mitochondrial stability inhibits Fas antibody induced
apoptosis
Bongkrekic acid (BA) stabilises the mitochondrial mem-
brane, preventing its disruption. Pre-incubation of neutrophils
for 1 h with 62 WM BA signi¢cantly inhibited anti-Fas anti-
body induced mitochondrial disruption and apoptosis (Fig.
2b), indicating that mitochondrial disruption is necessary for
the induction of apoptosis by Fas engagement. BA was also
able to signi¢cantly decrease corresponding increases in
caspase 3 activity but had no e¡ect on caspase 8 activity
(Fig. 2b). There may be some direct activation of caspase 3
by caspase 8, which has been suggested in other studies, as BA
was unable to completely block the e¡ects of anti-Fas anti-
body even though it did completely stabilise the mitochondrial
membrane.
Caspase 3 and 8 inhibitors and the mitochondrial stabiliser
BA were unable to prevent spontaneous apoptosis indicating
that activity of these caspases may not be directly involved in
spontaneous neutrophil apoptosis. We would postulate that
there are other caspases involved in this spontaneous process
that mediate their e¡ects independent of caspase 3 and 8.
Fig. 3. E¡ects of LPS and GM-CSF on anti-Fas antibody induced
apoptosis, mitochondrial and caspase changes. Neutrophils (1U106/
ml) were preincubated with LPS (1 Wg/ml) and GM-CSF (8 ng/ml)
for 1 h and then treated with anti-Fas antibody (CH-11, 100 ng/
ml). a: Neutrophil apoptosis was assessed by propidium iodide
DNA staining (18 h) and mitochondrial permeability (6 h) using Di-
OC6 staining detected by £ow cytometry. b: Caspase 3 and 8 activ-
ity was also assessed after 6 h, using AFC labelled substrates. The
rate of AFC £uorescence release was calculated and expressed as
pmol/s mg protein. *P6 0.05 vs control neutrophils, n = 5.
Fig. 2. E¡ects of caspase inhibitors (a) and BA (b) on anti-Fas anti-
body mediated apoptosis. Neutrophils (1U106/ml) were preincu-
bated with (a) Z-IETD-FMK (100 WM) and Z-DEVD-FMK (100
WM) or (b) BA (62 WM) for 1 h and then treated with or without
anti-Fas antibody (CH-11, 100 ng/ml). Apoptosis was assessed by
propidium iodide DNA staining after 18 h culture in vitro. Aliquots
of cells (10U105) were collected at 6 h and assessed for mitochon-
drial permeability using DiOC6 staining detected by £ow cytometry.
Caspase 3 and 8 activity was also assessed using AFC labelled sub-
strates and the rate of AFC £uorescence release was calculated and
expressed as pmol/s mg protein. *P6 0.05 vs control, n = 6.
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3.4. E¡ects of LPS and GM-CSF on anti-Fas antibody induced
caspase activity and mitochondrial permeability
Cellular resistance to Fas/Fasligand and TNF/TNFR1 in-
duced apoptosis has been demonstrated in a number of cell
systems. NF-UB activation renders lymphocytes, ¢broblasts
and macrophages refractory to the pro-apoptotic e¡ects of
TNF [22,23]. Interleukin-1L stimulates resistance in Jurkat
cells to Fas induced apoptosis [24]. Co-stimulation with LPS
and GM-CSF induces neutrophil resistance to Fas antibody
induced apoptosis [7]. Similarly, in£ammatory neutrophils iso-
lated from the lungs of LPS treated rats are resistant to anti-
Fas antibody and TNF induced apoptosis [12]. As shown in
Fig. 3, neutrophils preincubated with LPS (1 Wg/ml) and GM-
CSF (8 ng/ml) for 1 h before exposure to anti-Fas antibody
showed a signi¢cant reduction in rates of apoptosis. Similar
results were seen with annexin V binding; anti-Fas antibody
induced neutrophil apoptosis was reduced from 48 þ 12% to
10 þ 5% with LPS and 15 þ 4% with GM-CSF. Resistance to
apoptosis was associated with inhibition of mitochondrial per-
meability (Fig. 3), and reduced caspase 3 and 8 activity (Fig.
3), suggesting that LPS and GM-CSF inhibit the caspase cas-
cade at a step prior to caspase 8 activation.
3.5. E¡ects of NAC on anti-Fas induced caspase activity and
mitochondrial permeability
Augmentation of intracellular glutathione with NAC results
in resistance to anti-Fas induced apoptosis [7]. The protective
e¡ect of NAC was associated with inhibition of caspase 3 and
8 activity induced by anti-Fas antibody (Fig. 4a) and a sig-
ni¢cant reduction in the percentage of cells with mitochon-
drial injury (Fig. 4b). These results indicate that glutathione
not only inhibits caspase 8 activity, but also stabilises the
mitochondrial membrane. Glutathione has been shown to
block the ability of granzyme B to cleave poly(ADP-ribose)
polymerase, a caspase 3 dependent process [25]. In addition,
dithiocarbamate disulphide, a thiol regulating agent, inhibits
proteolytic processing of the caspase 3 pro-enzyme in Jurkat T
lymphocytes treated with anti-CD95 antibodies [26].
3.6. Direct e¡ect of glutathione on caspase activity
Glutathione was also shown to have a direct e¡ect on casp-
ase activity. Cell lysates, from neutrophils incubated for 6 h
with anti-Fas, were incubated with £uorogenic substrates for
caspase 3 and 8 with di¡ering, physiologic concentrations of
glutathione (1^10 mM) and assessed for caspase activity (Fig.
5). Glutathione resulted in signi¢cant dose dependent inhibi-
tion of caspase 3 and 8 activity. These e¡ects were speci¢c for
glutathione as diamide (0.5 mM, which chemically degrades
glutathione) signi¢cantly inhibited the e¡ects of glutathione
on caspase activity.
This study demonstrates that the in£ammatory mediators
that delay and inhibit Fas antibody induced apoptosis medi-
ate their e¡ect through stabilisation of the mitochondrial
membrane and caspase inhibition. These processes could
also be induced by increased glutathione, which was shown
Fig. 5. Glutathione regulation of caspase 3 and 8 activity. Cell ly-
sates were collected from 10U106 neutrophils incubated with anti-
Fas antibody (CH-11, 100 ng/ml) for 6 h. Lysates were then incu-
bated with 20 WM of £uorogenic substrates for caspase 3 (CBZ-
Asp-Glu-Val-Asp-AFC) and caspase 8 (CBZ-Ile-Glu-Thr-Asp-AFC)
with increasing concentrations of glutathione (1^10 mM). Diamide
(0.5 mM, which chemically breaks down glutathione) was incubated
with the glutathione (5 mM) solution for 1 h before addition as
above. Caspase activity was calculated as the rate of AFC £uores-
cence release and expressed as pmol/s mg protein. *P6 0.05 vs 0
mM GSH, n = 3.
Fig. 4. E¡ects of NAC on anti-Fas antibody and mClCCP induced
caspase and mitochondrial changes. a: Neutrophils (1U106/ml) were
preincubated with NAC (25 mM) for 1 h and then treated with
anti-Fas antibody (CH-11, 100 ng/ml). Caspase 3 and 8 activity was
assessed after anti-Fas antibody incubation for 6 h, using AFC la-
belled substrates. The rate of AFC £uorescence release was calcu-
lated and expressed as pmol/s mg protein. b: Mitochondrial disrup-
tion was also assessed at the same time, using DiOC6 staining
detected by £ow cytometry. *P6 0.05 vs control neutrophils,
2P6 0.05 vs Fas antibody treated neutrophils, n = 6.
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to directly inhibit caspase activity. Increased glutathione levels
during neutrophil activation may represent an important
mechanism to protect the cell against oxidative stress encoun-
tered during bacterial ingestion. In addition, thiols may pro-
tect the cell against caspase activation, allowing the cell to
survive longer and respond to an infectious challenge. Manip-
ulation of intracellular thiols may provide a mechanism for
regulating apoptosis in activated neutrophils, and thus pre-
vent the persistence of in£ammation and neutrophil mediated
tissue injury.
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